There is evidence that the drug semaglutide can help reduce the risk of dying from heart disease in some patients. The drug, sold under the brand names Wegovy, Ozempic, and Rybelsus, was studied in its injectable form at 2.
4mg for weight management. The study involved over 17,000 overweight or obese individuals with a history of heart issues. Results were presented at the American Heart Association meeting.
Source: Healthcare Press (healthcarepress.net)
Semaglutide Heart Disease Weight Management American Heart Association Study
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Obesity Drug Wegovy Cut Risk of Serious Heart Problems by 20%, Study FindsThe popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients.The research is the first to document that an obesity medication can not only...
Source: NEWSMAX - 🏆 16. / 71 Read more »
Source: KSLcom - 🏆 549. / 51 Read more »
Source: 10News - 🏆 732. / 50 Read more »
Obesity Drug Wegovy Cut Risk of Serious Heart Problems by 20 Percent Study FindsThe popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients.
Source: NEWSMAX - 🏆 16. / 71 Read more »
Source: KSLcom - 🏆 549. / 51 Read more »
Source: chicagotribune - 🏆 8. / 91 Read more »